| Primary |
| Drug Use For Unknown Indication |
37.8% |
| Analgesia |
9.2% |
| Pain |
7.6% |
| Abdominal Pain |
5.0% |
| Local Anaesthesia |
4.2% |
| Product Used For Unknown Indication |
4.2% |
| Colostomy |
3.4% |
| Hernia Repair |
3.4% |
| Premedication |
3.4% |
| Thyroid Cancer |
3.4% |
| Abdominal Pain Upper |
2.5% |
| Anaesthesia |
2.5% |
| Back Pain |
1.7% |
| Drug Abuse |
1.7% |
| Insomnia |
1.7% |
| Laparotomy |
1.7% |
| Mood Altered |
1.7% |
| Pancreatitis |
1.7% |
| Pancreatography |
1.7% |
| Sedative Therapy |
1.7% |
|
| Respiratory Depression |
50.8% |
| Drug Dependence |
5.1% |
| Grand Mal Convulsion |
5.1% |
| Skin Ulcer |
5.1% |
| Dystonia |
3.4% |
| Pancreatitis |
3.4% |
| Pneumonia |
3.4% |
| Respiratory Arrest |
3.4% |
| Acute Pulmonary Oedema |
1.7% |
| Amnesia |
1.7% |
| Dementia |
1.7% |
| Depression |
1.7% |
| Drug Exposure During Pregnancy |
1.7% |
| Electrocardiogram T Wave Amplitude Decreased |
1.7% |
| Electrocardiogram T Wave Inversion |
1.7% |
| Hepatic Failure |
1.7% |
| Mobility Decreased |
1.7% |
| Muscle Fibrosis |
1.7% |
| Muscular Weakness |
1.7% |
| Myopathy |
1.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.5% |
| Product Used For Unknown Indication |
18.8% |
| Insomnia |
6.6% |
| Sedation |
5.8% |
| Hypertension |
5.4% |
| Restlessness |
5.0% |
| Interstitial Lung Disease |
4.5% |
| Analgesic Therapy |
3.7% |
| Abdominal Pain |
3.5% |
| Duodenal Ulcer Perforation |
3.1% |
| Anaesthesia |
2.9% |
| Infection Prophylaxis |
2.5% |
| Foetal Exposure During Pregnancy |
2.3% |
| Induction And Maintenance Of Anaesthesia |
2.3% |
| Induction Of Anaesthesia |
2.3% |
| Therapeutic Embolisation |
2.3% |
| Pain |
1.7% |
| Analgesia |
1.6% |
| Constipation |
1.6% |
| Drug Dependence |
1.6% |
|
| Respiratory Depression |
14.3% |
| Injection Site Ulcer |
10.7% |
| Genital Haemorrhage |
9.5% |
| Toxic Epidermal Necrolysis |
9.5% |
| Injection Site Thrombosis |
7.1% |
| Electrocardiogram T Wave Inversion |
6.0% |
| Anaphylactic Shock |
4.8% |
| Drug Dependence |
4.8% |
| Respiratory Failure |
4.8% |
| Injection Site Necrosis |
3.6% |
| Respiratory Arrest |
3.6% |
| Dementia |
2.4% |
| Duodenal Ulcer Perforation |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Hepatic Failure |
2.4% |
| Hypopnoea |
2.4% |
| Muscle Contracture |
2.4% |
| Muscular Weakness |
2.4% |
| Nausea |
2.4% |
| Neonatal Tachypnoea |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.3% |
| Prophylaxis |
12.4% |
| Drug Use For Unknown Indication |
9.3% |
| Scleroderma |
7.3% |
| Insomnia |
5.2% |
| Pain |
5.0% |
| Fluid Replacement |
4.3% |
| Sedation |
4.3% |
| Back Pain |
3.9% |
| Hypertension |
3.0% |
| Multiple Myeloma |
3.0% |
| Hiv Infection |
2.7% |
| Infection Prophylaxis |
2.7% |
| Infection |
2.6% |
| Analgesic Therapy |
2.5% |
| Constipation |
2.2% |
| Premedication |
2.1% |
| Arthralgia |
1.7% |
| Diabetes Mellitus |
1.7% |
| Osteoarthritis |
1.7% |
|
| Overdose |
22.0% |
| White Blood Cell Count Decreased |
9.0% |
| Platelet Count Decreased |
6.5% |
| Respiratory Failure |
6.5% |
| Myocardial Infarction |
5.3% |
| Stomatitis |
5.3% |
| Cardiac Failure |
4.9% |
| Vomiting |
4.9% |
| Myocardial Ischaemia |
4.5% |
| Interstitial Lung Disease |
3.7% |
| Respiratory Depression |
3.7% |
| Infection |
3.3% |
| Pyrexia |
3.3% |
| Cardio-respiratory Arrest |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Jaundice |
2.4% |
| Pneumonia |
2.4% |
| Speech Disorder |
2.4% |
| Thrombocytopenia |
2.4% |
| Visual Impairment |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
58.8% |
| Spinal Cord Neoplasm |
14.7% |
| Pain |
8.8% |
| Blood Pressure |
5.9% |
| Convulsion |
5.9% |
| Traumatic Brain Injury |
5.9% |
|
| Drug Interaction |
40.0% |
| Vision Blurred |
40.0% |
| Nausea |
20.0% |
|
